Tradewinds Capital Management LLC Has $135,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Tradewinds Capital Management LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 14.3% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 272 shares of the healthcare conglomerate’s stock after buying an additional 34 shares during the period. Tradewinds Capital Management LLC’s holdings in UnitedHealth Group were worth $135,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Ameriprise Financial Inc. grew its position in UnitedHealth Group by 20.1% in the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock worth $1,879,245,000 after acquiring an additional 623,631 shares in the last quarter. Alps Advisors Inc. raised its position in shares of UnitedHealth Group by 111.0% in the 3rd quarter. Alps Advisors Inc. now owns 40,915 shares of the healthcare conglomerate’s stock worth $20,629,000 after acquiring an additional 21,526 shares in the last quarter. Adage Capital Partners GP L.L.C. boosted its position in shares of UnitedHealth Group by 10.0% during the third quarter. Adage Capital Partners GP L.L.C. now owns 925,866 shares of the healthcare conglomerate’s stock valued at $466,812,000 after purchasing an additional 84,215 shares in the last quarter. Evergreen Capital Management LLC boosted its holdings in UnitedHealth Group by 3.2% in the third quarter. Evergreen Capital Management LLC now owns 16,786 shares of the healthcare conglomerate’s stock worth $8,463,000 after acquiring an additional 519 shares in the last quarter. Finally, Elevatus Welath Management purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $226,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $7.78 during trading on Wednesday, reaching $490.46. The company had a trading volume of 1,350,946 shares, compared to its average volume of 4,270,184. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm has a market capitalization of $451.41 billion, a PE ratio of 30.01, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60. The firm’s fifty day moving average is $498.64 and its 200 day moving average is $501.12. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the firm earned $6.26 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a dividend of $2.10 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Wall Street Analyst Weigh In

A number of research firms recently commented on UNH. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Morgan Stanley decreased their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research report on Wednesday, June 5th. Barclays increased their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.